GlassScriptPhysician profile
Herbert G Rogers
NPI 1720092331
$2,597.21
in general payments reported to CMS, 2019-2025
32 companies · $176 in 2025
The $176 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $512 · 2021: $626 · 2022: $579 · 2023: $363 · 2024: $170 · 2025: $176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $709.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $604.61 | 2019-2025 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $354.45 | 2019-2023 | Verquvo, Steglatro, Segluromet |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.86 | 2019-2025 | Jardiance |
| Astellas Pharma US INC | $202.10 | 2019-2022 | |
| Abbott Laboratories | $166.40 | 2021-2023 | Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $139.94 | 2019-2023 | Lokelma |
| E.R. Squibb & Sons, L.L.C. | $130.56 | 2020-2024 | Eliquis |
| Janssen Pharmaceuticals, INC | $108.29 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $86.80 | 2024-2025 | Gemtesa |
| Novartis Pharmaceuticals Corporation | $84.39 | 2019-2023 | |
| Amgen INC. | $73.36 | 2019-2024 | Evenity, Prolia |
| Global Blood Therapeutics, INC. | $44.66 | 2020 | |
| Inspire Medical Systems, INC. | $34.80 | 2025 | Inspire |
| Alkermes, INC. | $32.00 | 2022 | |
| Biogen, INC. | $30.60 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $27.15 | 2019 | |
| Inari Medical, INC. | $21.84 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Dexcom, INC. | $19.50 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.47 | 2021 | |
| Aimmune Therapeutics, INC. | $19.15 | 2025 | Zenpep |
| Exact Sciences Corporation | $18.78 | 2024 | Cologuard Collection Kit |
| Abbvie INC. | $16.44 | 2021 | |
| Daiichi Sankyo INC. | $15.39 | 2021 | |
| Medtronic, INC. | $15.15 | 2022 | |
| Insulet Corporation | $14.08 | 2021 | |
| Redhill Biopharma INC. | $13.77 | 2020 | |
| Amarin Pharma, INC. | $13.58 | 2020 | |
| Tandem Diabetes Care, INC. | $13.26 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Nabriva Therapeutics, Plc | $12.75 | 2021 | |
| Glaxosmithkline, LLC. | $12.69 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.65 | 2019 | |
| Lilly USA, LLC | $11.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herbert Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.